Healthcare -
Biotechnology - NASDAQ - US
$ 31.49
-0.317 %
$ 14 B
Market Cap
12.4
P/E
RPRX - TOTAL LIABILITIES & EQUITY
Total Liabilities & Equity RPRX - Royalty Pharma plc
16.4 B
LAST VALUE
-3.29%
2 YEAR CAGR
7.58%
5 YEAR CAGR
0.00%
10 YEAR CAGR